Actionable news
All posts from Actionable news
Actionable news in CELG: Celgene Corporation,

Celgene (CELG) Down In Early Morning Trading

Trade-Ideas LLC identified Celgene ( CELG) as a pre-market laggard candidate. In addition to specific proprietary factors, Trade-Ideas identified Celgene as such a stock due to the following factors:

  • CELG has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $440.0 million.
  • CELG traded 60,680 shares today in the pre-market hours as of 8:42 AM.
  • CELG is down 2% today from yesterday's close.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in CELG with the Ticky from Trade-Ideas. See the FREE profile for CELG NOW at Trade-Ideas More details on CELG: Celgene Corporation discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases worldwide. CELG has a PE ratio of 57. Currently there are 14 analysts that rate Celgene a buy, no analysts rate it a sell, and 3 rate it a hold. The average volume for Celgene has been 5.6 million shares per day over the past 30 days. Celgene has a market cap of $86.4 billion and is part of the health care sector and drugs industry. The stock has a beta of 1.61 and a short float of 1.3% with 2.00 days to cover. Shares are down 10.3%...